Study: Shingles vaccine is effective for seniors but few get it

04/10/2013 | HealthDay News

An analysis of data from more than 700,000 Medicaid beneficiaries found that the shingles vaccine is effective at reducing the risk of shingles and post-herpetic neuralgia, but only 4% in the study group received it. The vaccine reduced the rate of shingles by 48% and post-herpetic neuralgia by 59% overall. The study appeared in the journal PLoS Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT